Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patterns of Treatment Failure and Safety of Thoracic Radiotherapy Combined With EGFR-TKI in Stage III EGFR-mutant Lung Adenocarcinoma: a Multicenter Retrospective Cohort Study

NCT07857694 is registered in ClinicalTrials.gov with Laibin People's Hospital as lead sponsor.

NCT NCT07857694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07857694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patterns of Treatment Failure and Safety of Thoracic Radiotherapy Combined With EGFR-TKI in Stage III EGFR-mutant Lung Adenocarcinoma: a Multicenter Retrospective Cohort Study
Lead sponsor
Laibin People's Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2020
Completion date
September 29, 2026
Enrollment
202 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

egfr activating mutation, lung cancer stage iii